abstract |
The present invention relates to a method for inducing an antigen-specific immune response, a method for enhancing immune cell binding to an antigen, a method for increasing the number of immune cells specific for an antigen, a method for preventing or treating infection and a vaccine With regard to the method of inoculation, the method comprises administering a combination of an interleukin-4 receptor (IL-4R) antagonist and an antigen, in particular an HIV-1 antigen selected from gag, pol or env. |